Clinical Trial:
Canine Hip Osteoarthritis

Purpose of the Study

Arthritis is estimated to affect up to 60% of the 90 million adult dogs in the United States.

This trial is designed to evaluate a naturally derived biomaterial to help restore proper joint mechanics by joint injection. 

Up to 25 dogs with unilateral or bilateral hip arthritis (confirmed by radiographs) will be included in the study and the study will be completed over 90 days. 

Enroll Before November 15th!

Contact to Enroll

Call: (303) 545-2273 

Email: pain@coloradoanimalspecialty.com 

Colorado Animal Specialty & Emergency 
2972 Iris Ave, Boulder CO 80301 

Inclusion Criteria 

  • Age: 2-12 years old 

  • Weight: 20-100 lbs (10-50kg) 

  • Lameness in one or both rear legs 

  • Radiographic evidence of hip osteoarthritis 

Exclusion Criteria 

  • Neurologic disease 

  • Prior hip injection within the last 6 months 

  • Corticosteroid use within the last 3 months 

  • Active cranial cruciate ligament disease 

  • Pain with palpation of the feet, knees, or tarsi 

Participation Requirements

  • Must be local to Boulder, CO

  • 3 month study 

  • 4 office visits 

  • 1 injection 

Benefits 

  • Proven safety profile for humans and animals 
    The biomaterial we are studying was originally extensively tested as a dermal filler, and has excellent clinical tolerability in trials for horses, dogs and cats. 

  • Quality medical and physical screening at no cost 
    Each dog will receive a full physical exam, comprehensive labwork, and radiographs of the hips.

  • All dogs in the study will receive the product

Study Conducted By

James Gaynor
DVM, MS, DACVAA 

Diplomat of the American College of Anesthesia and Analgesia

The product statements included herein represent the views and the representation of PetVivo and do not necessarily represent the view or representations of the investigators at CASE.